BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 425 | Download: 703
 |
Received |
|
2021-02-26 21:25 |
|
Peer-Review Started |
|
2021-02-26 21:33 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-07 20:25 |
|
Revised |
|
2021-05-19 20:27 |
|
Second Decision |
|
2021-08-09 02:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-09 05:39 |
|
Articles in Press |
|
2021-08-09 05:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-19 15:20 |
|
Publish the Manuscript Online |
|
2021-08-23 06:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Adjuvant therapy for lung neuroendocrine neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Robert A Ramirez, Katharine Thomas, Aasems Jacob, Karen Lin, Yvette Bren-Mattison and Aman Chauhan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Robert A Ramirez, Consultant, FACP, Associate Professor, Department of Medicine-Division of Hematology/Oncology, Vanderbilt University Medical Center, 2220 Pierce Ave, 7770 Preston Research Building, Nashville, TN 37232, United States. robert.ramirez@vumc.org |
| Key Words |
Neuroendocrine; Adjuvant therapy; Lung; Pulmonary carcinoid; Small cell lung cancer |
| Core Tip |
Neuroendocrine neoplasms of the lung are uncommon malignancies. They vary in degrees of aggressiveness from the slow growing typical carcinoid tumors to the very fast-growing small cell lung cancer. While surgical resection should be considered for early-stage disease, the role of adjuvant therapy is less well established. Guidelines from different organizations vary, citing a lack of trials to support a high-level recommendation. This manuscript will discuss the evidence for and against adjuvant therapy in neuroendocrine neoplasms of the lung. |
| Publish Date |
2021-08-23 06:43 |
| Citation |
Ramirez RA, Thomas K, Jacob A, Lin K, Bren-Mattison Y, Chauhan A. Adjuvant therapy for lung neuroendocrine neoplasms. World J Clin Oncol 2021; 12(8): 664-674 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/664.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.664 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
